Ventas (VTR)
(Delayed Data from NYSE)
$62.53 USD
-0.04 (-0.06%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $62.54 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$62.53 USD
-0.04 (-0.06%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $62.54 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum D VGM
Zacks News
Key Factors to Impact Prologis' (PLD) Earnings This Season
by Zacks Equity Research
Prologis' (PLD) Q3 results likely to reflect healthy fundamentals of the industrial real estate market backed by an improving economy and strengthening e-commerce market.
Here's Why You Should Hold Ventas in Your Portfolio Now
by Zacks Equity Research
While a diversified portfolio insulates Ventas' (VTR) performance from any unfavorable market swings, elevated supply of senior housing assets could impact its pricing power in the near future.
Ventas Enhances New York Portfolio With Battery Park Buyout
by Zacks Equity Research
Amid stiff competition with healthcare operators, Ventas (VTR) cracks an attractive deal to acquire Battery Park from Brookdale for around $194 million.
HT or VTR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HT vs. VTR: Which Stock Is the Better Value Option?
Will Rising Healthcare Spending Aid HCP This Earnings Season?
by Zacks Equity Research
HCP Q2 results likely to reflect benefit from shedding of Brookdale assets. However, rising interest rates remains a concern.
Ventas' (VTR) Q2 FFO & Revenues Trump Estimates, NOI Up
by Zacks Equity Research
Ventas' (VTR) Q2 results highlight the company's efforts to diversify its business into university-based life-science projects.
AHT or VTR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AHT vs. VTR: Which Stock Is the Better Value Option?
Ventas (VTR) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Ventas (VTR) delivered earnings and revenue surprises of 5.88% and 2.57%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Ventas (VTR) Q2 FFO and Revenues Beat Estimates
by Zacks Equity Research
Ventas (VTR) Q2 results highlight better-than-expected increase in revenues.
What's in Store for Boston Properties (BXP) in Q2 Earnings?
by Zacks Equity Research
Boston Properties' (BXP) Q2 results are anticipated to reflect benefit from solid demand for its properties amid improving economy and job market gains. However, rising supply remains a concern.
Simon Property (SPG) to Post Q2 Earnings: What to Expect?
by Zacks Equity Research
Simon Property's (SPG) Q2 performance expected to display favorable impact of the company's efforts to beat retail blues by focusing on new development, redevelopment, expansion and acquisitions.
Should You Buy Ventas (VTR) Ahead of Earnings?
by Zacks Equity Research
Ventas (VTR) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
IRM & VTR Q2 Earnings on Jul 27: Here are the Key Predictions
by Zacks Equity Research
Will Iron Mountain Incorporated (IRM) and Ventas (VTR) beat Q2 estimates this earnings season?
Will Favorable Demographic Trends Support UDR Q2 Earnings?
by Zacks Equity Research
UDR's Q2 results likely to reflect gains from favorable demographic trends, improvement in economy and job market gains. However, rising deliveries of new units remains a concern.
What's in Store for AvalonBay (AVB) This Earnings Season?
by Zacks Equity Research
AvalonBay (AVB) Q2 results likely to reflect benefits from favorable demographics and job growth. However, rising supply remains a drag.
Ventas (VTR) Gears Up for Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Ventas' (VTR) Q2 performance expected to reflect favorable impact of the rising aging population as well as the company's strategic agreement with Brookdale.
Iron Mountain (IRM) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Iron Mountain's (IRM) Q2 performance will likely reflect the impact of intense competition in North America, as well as declining activity rates in the company's Services sector.
What's in the Cards for Kimco (KIM) This Earnings Season?
by Zacks Equity Research
Kimco Realty's (KIM) Q2 results will likely reflect the benefit of its portfolio-revamp efforts, progress on 2020 Vision, high consumer confidence and improving economy, despite an e-retail boom.
Key Factors to Impact Equity Residential (EQR) Q2 Earnings
by Zacks Equity Research
Equity Residential's (EQR) Q2 results are likely to gain from strong rental housing demand. However, higher supply is likely to dent growth.
Key Factors to Impact Digital Realty's (DLR) Q2 Earnings
by Zacks Equity Research
Digital Realty's (DLR) Q2 performance is likely to reflect impact of healthy industry fundamentals and strategic acquisitions. However, aggressive pricing pressure remains a drag.
Key Factors to Impact SL Green (SLG) Earnings This Season
by Zacks Equity Research
SL Green Realty's (SLG) Q2 results will likely reflect the company's efforts to reposition its portfolio through accretive acquisitions and non-core dispositions.
Key Factors to Impact Prologis' (PLD) Earnings This Season
by Zacks Equity Research
Healthy fundamentals of industrial real estate market amid improving economy and e-commerce boom are likely to have aided Prologis' (PLD) Q2 results. Yet, competition and rising supply remain woes.
XHR vs. VTR: Which Stock Is the Better Value Option?
by Zacks Equity Research
XHR vs. VTR: Which Stock Is the Better Value Option?
XHR vs. VTR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
XHR vs. VTR: Which Stock Is the Better Value Option?
Ventas (VTR) Up 11.8% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Ventas (VTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.